Jan 4.
Health:
Australia, and New Zealand) remains important given the high prevalence of BTC and GEA in the
APAC region.
Through our collaboration with BeiGene on zanidatamab, we remain eligible to receive up to $195 million in additional…
Australia, and New Zealand) remains important given the high prevalence of BTC and GEA in the
APAC region.
Through our collaboration with BeiGene on zanidatamab, we remain eligible to receive up to $195 million in additional…